乳腺疾病血清催乳素测定的临床意义

被引：9

作者：

谷成明

姜军

黄朴厚

詹新恩

机构：

[1] 西南医院普通外科乳腺组

来源：

第三军医大学学报 | 1989年 / 04期

关键词：

乳腺疾病; 乳腺肿瘤; 催乳素; 放射免疫测定; 催乳素测定; 监测系统;

D O I：

10.16016/j.1000-5404.1989.04.009

中图分类号：

学科分类号：

摘要：

用放射免疫法测定184例正常乳腺、良性乳腺疾病和乳腺癌患者血清催乳素浓度。结果显示:3组良性乳腺疾病血清催乳素含量无差别;乳腺癌及良性乳腺疾病均高于正常人;乳腺癌组明显高于良性乳腺疾病组;乳腺癌术后血中催乳素含量恢复正常。提示:循环血中催乳素异常升高可能是良性乳腺疾病发病原因之一,并与乳腺癌的发生、发展有密切关系。测定催乳素有助于乳腺良、恶性疾病的诊断及鉴别诊断,可作为乳腺癌预后的随访指标。

引用

页码：274 / 276

页数：3

共 9 条

[1]

Rose DP. et al.Plasma prolactin levels in patients with breast cancer. Cancer . 1981

[2]

Malarkey WB.Disordered nocturnal prolactin regulation in women with breast cancer. Cancer Research . 1977

[3]

Frantz AG.Prolactin. The New England Journal of Medicine . 1978

[4]

Wills KJ,et al.Recurrent breast cancer treated with the antiestrogen tamoxifen: Correlation between hormonal changes and clinical course. British Medical Journal . 1977

[5]

Manni A. et al.Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenanthracene-induced rat mammary tumor. Cancer Research . 1977

[6]

Cole EN.Serum prolactin concentration in benign breast disease throughout the menstrual cycle. European Journal of Cancer . 1977

[7]

Manni A. et al.Promotion by prolactin of the growth of human breast neoplasm cultured in vitro in the soft agar clonogenic assay. Cancer Research . 1986

[8]

Hill P.Diet and prolactin release. The Lancet . 1976

[9]

Prose D.Biocative prolactin and potential for reducing breast cancer risk. Preventive Medicine . 1986

← 1 →